Name: UMIN ID:
Unique ID issued by UMIN | UMIN000030551 |
---|---|
Receipt number | R000034877 |
Scientific Title | Phase I study of nab-paclitaxel and gemcitabine chemoradiotherapy for borderline resectable and locally advanced unresectable pancreatic ductal adenocarcinoma |
Date of disclosure of the study information | 2017/12/25 |
Last modified on | 2020/06/27 14:27:24 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2017/12/25 02:51:12 | ||
2 | Update | 2018/02/16 00:56:11 | Recruitment status |
|
3 | Update | 2019/06/28 20:18:15 | Date of IRB Last follow-up date |
|
4 | Update | 2019/06/28 22:08:08 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Email3 Organization Organization Address Address Tel |
|
5 | Update | 2020/06/27 14:21:22 | Recruitment status Last follow-up date |
|
6 | Update | 2020/06/27 14:25:42 | Email1 Email3 |
|
7 | Update | 2020/06/27 14:27:24 | Number of participants that the trial has enrolled |